Extendicare (OTCMKTS:EXETF) Trading Up 1.9% – Here’s What Happened

Shares of Extendicare Inc. (OTCMKTS:EXETFGet Free Report) rose 1.9% on Monday . The stock traded as high as $19.58 and last traded at $19.58. Approximately 100 shares were traded during trading, a decline of 97% from the average daily volume of 3,545 shares. The stock had previously closed at $19.2120.

Wall Street Analyst Weigh In

EXETF has been the subject of a number of research analyst reports. BMO Capital Markets raised Extendicare from a “market perform” rating to an “outperform” rating in a research note on Thursday, December 4th. National Bank Financial reaffirmed an “outperform” rating on shares of Extendicare in a research report on Thursday, December 4th. Finally, Royal Bank Of Canada upgraded Extendicare from a “sector perform” rating to an “outperform” rating in a report on Thursday, December 4th. Four analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy”.

View Our Latest Research Report on EXETF

Extendicare Trading Up 1.9%

The business’s fifty day moving average is $17.68 and its 200 day moving average is $14.48.

Extendicare Company Profile

(Get Free Report)

Extendicare Inc (OTCMKTS:EXETF) is a Canada-based senior care provider headquartered in Markham, Ontario. The company specializes in the ownership and operation of long-term care homes, retirement residences and home health care services. It is publicly listed on the Toronto Stock Exchange under the symbol EXE and trades in the over-the-counter market as EXETF.

Extendicare’s operations are organized into two primary segments. The Long-Term Care & Retirement Living division operates approximately 120 facilities under the Extendicare and EspritVitalité banners, serving residents in Ontario, Alberta, Saskatchewan and parts of Atlantic Canada.

Further Reading

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.